Chlormerodrin hg 197
Chlormerodrin hg 197 is a small molecule pharmaceutical. Chlormerodrin hg 197 was first approved as Chlormerodrin hg 197 on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chlormerodrin hg-197
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CHLORMERODRIN HG 197 | Bracco Diagnostics | N-017269 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
617 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Surgical wound infection | D013530 | 2 | 9 | 11 | 13 | 18 | 51 | ||
| Gingivitis | D005891 | K05.10 | 1 | 4 | 6 | 6 | 12 | 29 | |
| Infections | D007239 | EFO_0000544 | 1 | 1 | 5 | 5 | 14 | 26 | |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | 4 | 3 | 9 | 9 | 25 |
| Covid-19 | D000086382 | U07.1 | 4 | 8 | 1 | 4 | 5 | 20 | |
| Periodontal diseases | D010510 | K05.6 | — | 2 | 3 | 3 | 13 | 19 | |
| Dental caries | D003731 | EFO_0003819 | K02 | 2 | 2 | 7 | 1 | 8 | 19 |
| Ventilator-associated pneumonia | D053717 | EFO_1001865 | J95.851 | 2 | 2 | 4 | 1 | 7 | 16 |
| Dental plaque | D003773 | 3 | 3 | 3 | 3 | 6 | 16 | ||
| Bacteremia | D016470 | EFO_0003033 | R78.81 | 1 | — | 1 | 6 | 6 | 14 |
Show 78 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | 1 | 2 | 1 | — | 4 | 6 |
| Wounds and injuries | D014947 | T14.8 | — | — | 1 | — | 3 | 4 | |
| Neonatal sepsis | D000071074 | HP_0040187 | — | 1 | 1 | — | 2 | 3 | |
| Infant mortality | D007226 | — | — | 2 | — | 1 | 3 | ||
| Periapical periodontitis | D010485 | EFO_1001391 | K04.5 | — | — | 1 | — | 2 | 3 |
| Postoperative complications | D011183 | — | — | 2 | — | 1 | 3 | ||
| Communicable diseases | D003141 | — | — | 2 | — | 1 | 3 | ||
| Esophageal neoplasms | D004938 | C15 | — | 1 | 1 | — | 2 | 3 | |
| Respiratory tract infections | D012141 | J06.9 | 1 | 1 | 2 | — | — | 3 | |
| Neoplasms | D009369 | C80 | — | — | 1 | — | 1 | 2 |
Show 27 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Halitosis | D006209 | R19.6 | 1 | 1 | — | — | 3 | 4 | |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 3 | — | — | — | 3 |
| Drug-related side effects and adverse reactions | D064420 | T88.7 | 2 | 2 | — | — | 1 | 3 | |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | 1 | 1 | — | — | — | 2 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 1 | — | — | — | 2 |
| Cesarean section | D002585 | — | 1 | — | — | 1 | 2 | ||
| Oropharyngeal neoplasms | D009959 | — | 1 | — | — | 1 | 2 | ||
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | 1 | 2 |
| Fever | D005334 | HP_0001945 | R50.9 | 1 | 1 | — | — | — | 1 |
| Warts | D014860 | B07 | — | 1 | — | — | — | 1 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | 1 | — | — | — | 1 | 2 | ||
| Disease | D004194 | EFO_0000408 | R69 | 1 | — | — | — | 1 | 2 |
| Cerebral hemorrhage | D002543 | 1 | — | — | — | — | 1 | ||
| Ingrown nails | D009263 | L60.0 | 1 | — | — | — | — | 1 | |
| Rhinoplasty | D012225 | 1 | — | — | — | — | 1 | ||
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
| Pulmonary heart disease | D011660 | I27.81 | 1 | — | — | — | — | 1 | |
| Diabetic angiopathies | D003925 | EFO_1000896 | 1 | — | — | — | — | 1 | |
| Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | 1 | — | — | — | — | 1 |
| Stomatognathic diseases | D009057 | K08.9 | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hydrogen-ion concentration | D006863 | — | — | — | — | 3 | 3 | ||
| Coronary disease | D003327 | — | — | — | — | 2 | 2 | ||
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | — | 2 | 2 |
| Abscess | D000038 | EFO_0003030 | — | — | — | — | 2 | 2 | |
| Furunculosis | D005667 | L02.92 | — | — | — | — | 2 | 2 | |
| Oral candidiasis | D002180 | EFO_0007406 | B37.0 | — | — | — | — | 2 | 2 |
| Rosacea | D012393 | L71 | — | — | — | — | 2 | 2 | |
| Risk reduction behavior | D040242 | — | — | — | — | 2 | 2 | ||
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 2 | 2 |
| Cicatrix | D002921 | HP_0100699 | L90.5 | — | — | — | — | 2 | 2 |
Show 71 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CHLORMERODRIN HG 197 |
| INN | chlormerodrin (197hg) |
| Description | Chlormerodrin hg 197 is a small molecule pharmaceutical. Chlormerodrin hg 197 was first approved as Chlormerodrin hg 197 on 1982-01-01. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 64461-80-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201095 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 1D6EFC579A (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 5 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,601 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more